The case for expanding screening for pancreatic cancer in those with new onset of diabetes and weight loss.
Read More »Managing Editor, Diabetes in Control
SGLT-2 Inhibitors and the Risk for Urosepsis
Are SGLT-2 inhibitors responsible for urosepsis or Fournier's gangrene?
Read More »The Relationship Between Aerobic Exercise Capacity and Cardiac Dysfunction In T2D
In type 2 diabetes patients, treating diastolic function and myocardial perfusion reserve could improve aerobic exercise capacity and prevent heart failure.
Read More »Possible Link Connecting COVID-19 and New-Onset Diabetes
CoviDIAB Registry will explore why COVID-19 can increase complications in people with pre-existing diabetes, and may also be driving new cases.
Read More »Adding An SGLT-2 Earlier To A Treatment Plan Yields Positive A1c Levels
If dapagliflozin is the second medication prescribed to the patient after the first-line treatments of metformin or sulfonylurea, it has a greater impact.
Read More »Simple Strategies to Prevent Cardiovascular Complications in T2D
Explore three methods to prevent future acute myocardial infarction with diabetes as an underlying agent.
Read More »Heart Rate Variability as a Predictor for the Development of Diabetes
Decreased vagal tone and changes in sympathetic activity may precede the development of cardiometabolic disease or diabetes.
Read More »An Alternative Option for Weight and Glycemia Reduction
Infusion of certain hormones could help in reducing patient weight and glucose levels.
Read More »Vitamin D Deficiency Linked to Painful Diabetic Neuropathy
As patients’ vitamin D levels rose, the pain and other symptoms of painful diabetic neuropathy decreased.
Read More »Obesity at Different Ages Can Determine Different Outcomes in Diabetes
Age at onset of obesity and number of obese years are crucial factors in type 2 diabetes risk.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.